Literature DB >> 21043007

Giant cell hepatitis: an unusual cause of fulminant liver failure.

J Hartl1, R Buettner, F Rockmann, S Farkas, A Holstege, C Vogel, A Schnitzbauer, H J Schlitt, J Schoelmerich, G Kirchner.   

Abstract

Giant cell hepatitis is a very rare disease of unknown origin. It has been hypothesized that drugs, viral infections, or autoimmune reactions may play a pathogenetic role. Here, we describe a 33 year old patient with bacterial bronchitis who was treated with doxycycline (100 mg/d) for one week. Furthermore the patient complained of malaise and a distinct jaundice. Liver parameters increased dramatically (AST 4670 U/l, ALT 5350 U/l, bilirubin 226 µmol/l) and liver function was impaired (INR = 1,45). The ultrasound scan showed a hepatomegaly with no signs of cirrhosis, normal spleen size and normal bile ducts; liver perfusion was normal. No evidence of Wilson's disease, hemochromatosis, autoimmune hepatitis, primary sclerosing cholangitis, primary biliary cirrhosis, hepatitis A, B, C and E, HIV, CMV, VZV, adenoviral infections, or paracetamol intoxication was found. Subsequently, the patient developed acute liver failure (AST 2134 U/l, ALT 2820 U/l, bilirubin 380 µmol/l, INR 3.0) and a beginning renal failure. Therefore, he was transferred to our transplant center. Due to increasing confusion and somnolence due to cerebral edema mechanical ventilation was needed. Because of an acute renal failure and severe hepatic encephalopathia MARS-hemodialysis was performed. Three weeks after the appearance of the jaundice he underwent liver transplantation (MELD 40). Surprisingly, in the explanted liver the diagnosis of giant cell hepatitis was made. Today--2 years after successful liver transplantation--the patient is in very good condition with normal liver function. In conclusion, giant cell hepatitis is a rare cause of acute liver failure that is often recognized only histologically. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2010        PMID: 21043007     DOI: 10.1055/s-0029-1245476

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  3 in total

1.  Management of giant cell hepatitis associated with chronic lymphocytic leukemia - a case series and review of the literature.

Authors:  Joanna M Rhodes; Stephen J Schuster; Emma E Furth; Kaitlin Kennard; Sunita Dwivedy Nasta; Jakub Svoboda; David L Porter; Anthony R Mato
Journal:  Cancer Biol Ther       Date:  2019-05-15       Impact factor: 4.742

2.  Postinfantile giant cell hepatitis: an etiological and prognostic perspective.

Authors:  Chhagan Bihari; Archana Rastogi; Shiv Kumar Sarin
Journal:  Hepat Res Treat       Date:  2013-03-11

3.  Postinfantile Giant Cell Hepatitis with Features of Acute Severe Autoimmune Hepatitis Probably Triggered by Diclofenac in a Patient with Primary Myelofibrosis.

Authors:  Pinelopi Arvaniti; Kalliopi Zachou; George K Koukoulis; George N Dalekos
Journal:  Case Reports Hepatol       Date:  2018-03-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.